Clinical Trial Update: LILRB4 STAR-T Cell Therapy for Monocytic Leukemia [NA]

View source ↗

Summary

A clinical trial evaluating LILRB4 STAR-T Cell Therapy for monocytic leukemia has completed its study for Acute Myeloid Leukemia and Chronic Myelomonocytic Leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelomonocytic Leukemia

Drugs mentioned

• LILRB4 STAR-T Cell Therapy

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia | NA | Status: COMPLETED